Certara
Certara is a biosimulation and technology-enabled drug development company that provides software, consulting, and regulatory services to pharmaceutical, biotech, and regulatory agency clients to improve the efficiency and success rates of bringing new therapies to market. Its offerings include model-informed drug development platforms, pharmacometrics and regulatory strategy consulting, and real-world evidence and market access solutions, sold primarily via software licenses, SaaS subscriptions, and professional services engagements.
- IT Consulting & Implementation
- Revenue
- $380.0M
- Employees
- 1,500
- Founded
- 2008
- Headquarters
- Princeton, United States of America
What 19 Arbolus experts think of Certara
NPS scores for Certara are predominantly favorable, with most experts rating 8-10, but a notable minority show mid-tier scores (6-7) and are undecided about renewal. A significant portion report over one year of implementation, correlating with higher loyalty. Key positive themes include regulatory alignment, data reliability, and audit-ready results. However, cost, speed of delivery, and automation needs are frequent concerns. Some experts plan to reduce spend as in-house analytics mature. The overall sentiment is positive but tempered by pricing sensitivity and strategic re-evaluation.Overall Customer Sentiment: Positive
Who reviewed Certara
- C-Suite 56% (11)
- Director 39% (7)
- Manager 6% (1)
Employer names and spend open in the full report, along with the other 16 customers.
Everything 19 customers told us about Certara.
Employer names, spend, renewal intent and every written answer behind the numbers on this page.
Sentiment
36 Net Promoter Score, from 19 scored reviews- Promoters 9
- Passives 8
- Detractors 2
Cumulative NPS by month
+0 over 6 months- Apr 8
- May 8
- Jun 8
- Jul 8
- Aug 8
- Sep 8
Net Promoter Score across 1 reviews, accumulated up to each month. Category median 36 across 1 companies.
Praised
- Audit-Ready and Regulatory Alignment
- Strong Data Reproducibility
- Supports Compliance Obligations
- AI-Driven Workflow Automation
Criticised
- Limited Flexibility for Automation
- Slower Turnaround for Audit Results
- High Cost is a Barrier
- In-House Development for Cost Control
What customers say
Renewal intent
Plan to renew 47%Plan to renew, by seniority
- 29% 7 answers
- 67% 6 answers
- 0% 1 answer
- 100% 1 answer
- 9/10 Average score from customers who will renew
- 7.3/10 Average score from undecided customers
- 7/10 Average score from customers not renewing
Report
More in Data & Analytics and ERP Software
Other companies in both categories with a customer report.
For people who use Certara
Do you use Certara at work?
Share your software review and get matched to paid projects. Arbolus pays you every time a client reads your review.
- 19 customers of Certara have already contributed
Takes a few minutes. Your identity stays anonymous.